The FDA cleared expanded indications for Medtronic‘s (NYSE:MDT) CoreValve TAVR devices, now cleared for use in patients with end-stage renal disease and those with low-grade, low-flow aortic stenosis. Medtronic won approval from the FDA to modify the CoreValve’s labeling in November which included both its CoreValve and CoreValve Evolut R systems. The changes to the labeling […]
Medtronic
Urologix sold to settle debt to Medtronic
Urologix Inc. (OCT:ULGX) yesterday said it sold almost all of its assets to a secured creditor, which then sold them to a private company that will operate the business as Urologix LLC. The remnants of Urologix Inc. were renamed 21st North Inc. The Minneapolis-based company, which makes the Cooled ThermoTherapy and Prostiva RF devices to treat benign […]
Medtronic wins expanded CE Mark for larger Resolute Onyx stent
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for a expanded indications and sizes for its Resolute Onyx drug-eluting stent. The Resolute Onyx device is based on Medtronic’s Resolute Integrity DES, but uses the Fridley, Minn.-based firm’s new CoreWire technology to wrap a cobalt alloy around a denser metal to increase […]
Medtronic, St. Jude amongst firms to present data at FDA leadless pacer meeting
Medtronic (NYSE:MDT) and St. Jude Medical (NYSE:STJ) are among medtech firms who have said they will present data on their leadless pacing systems, the Micra and Nanostim, at an FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee. The panel is meeting on Feb. 18 in Gaithersburg, Md. to discuss leadless cardiac pacemaker device technology […]
Medtronic gets into renal care with Bellco acquisition
Medtronic (NYSE:MDT) said today that it acquired renal care products make Bellco for an undisclosed amount and plans to fold it into a newly created renal care solutions division. Fridley, Minn.-based Medtronic said Mirandola, Italy-based Bellco makes devices designed to treat end-stage renal failure, multiple organ failure and sepsis, including dialyzers and chronic and acute dialysis machines. The […]
Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves
Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based company said Jellison, who’s been with Styker for 3 years, will pursue positions on boards and devote more time to his family. Jellison will stay on through […]
Minn. court resurrects lawsuit over Medtronic’s Covidien buyout
A Minnesota appeals court yesterday revived a lawsuit filed by Medtronic (NYSE:MDT) shareholders looking to block the mega-merger with Covidien that closed a year ago today. Medtronic paid $50 billion to acquire Covidien in the biggest medical device acquisition ever. But shortly after the deal was announced during the summer of 2014, shareholder Lewis Merenstein sued in Hennepin County […]
Intuitive Surgical CEO Guthart unfazed by upcoming competition
Gary Guthart, the longtime CEO of robot-assisted surgery pioneer Intuitive Surgical (NSDQ:ISRG), said yesterday that he’s confident Intuitive will be able to compete as smaller rivals begin hitting the market as early as this year and bigger players loom on the horizon. “We have known for years and have anticipated for years. We didn’t wake up yesterday […]
Medtronic inks $221m IRS settlement
Medtronic (NYSE:MDT) agreed to pay out up to nearly $221 million to settle a tax dispute with the U.S. Internal Revenue Service that it inherited when it bought Covidien last year. The IRS dunned Covidien’s corporate predecessor, Tyco International, in June 2013, disallowing deductions it took from 1997 to 2000 for some $2.8 billion in loans made […]
Supremes remand Medtronic lawsuit against NuVasive to lower court
The U.S. Supreme Court today remanded a Medtronic (NYSE:MDT) lawsuit against longtime spinal implant rival NuVasive Inc. (NSDQ:NUVA) to a lower appeals court, after deciding last year that a defendant’s belief regarding patent validity is not a defense to an induced infringement claim. Last July Medtronic asked the U.S. Supreme Court to review the U.S. Court of Appeals for the […]
Bioventus taps ex-Medtronic CEO Hawkins for chairman | Personnel Moves
Bioventus said it tapped former Medtronic (NYSE:MDT) and Immucor (NSDQ:BLUD) chief Bill Hawkins to be its new chairman, replacing Dan LeMaitre. Hawkins, who’s slated to appear at the upcoming DeviceTalks event in Raleigh, N.C., had the corner office at Medtronic from 2007 until 2011, when he took the helm at Immucor, where is he lead director. […]